Malcisbo raises €3.6M Seed round
19 September 2011· Schlieren, Switzerland· health, biotech, animal_health, b2b, materials
The funding was to advance the company's technology for developing vaccines against parasites and bacteria infecting humans and animals.
Investors
Leadprivate investors
Also participating
business angelsZürcher Kantonalbank Startup FinanceRedalpine Venture Partners AG
About Malcisbo
Stage
Growth
Headquarters
Schlieren, Switzerland
Founded
2009
Team Size
6–20
Sectors
healthbiotechanimal_healthb2bmaterials